159316 创新药E
已收盘 09-30 15:00:00
资讯
新帖
简况
【ETF动向】9月29日创新药ETF银华基金跌0.12%,份额增加1.61亿份
证券之星 · 09-30
【ETF动向】9月29日创新药ETF银华基金跌0.12%,份额增加1.61亿份
【ETF动向】9月29日港股通创新药ETF汇添富基金涨2.76%,份额减少1.1亿份
证券之星 · 09-30
【ETF动向】9月29日港股通创新药ETF汇添富基金涨2.76%,份额减少1.1亿份
【ETF动向】9月29日港股创新药ETF银华基金涨3.07%,份额减少9000万份
证券之星 · 09-30
【ETF动向】9月29日港股创新药ETF银华基金涨3.07%,份额减少9000万份
ETF热点速递|康方生物放量大涨13%,港股通创新药ETF、恒生创新药ETF、港股创新药ETF涨超2%
格隆汇 · 09-29
ETF热点速递|康方生物放量大涨13%,港股通创新药ETF、恒生创新药ETF、港股创新药ETF涨超2%
【ETF动向】9月28日创新药ETF银华基金涨0.48%,份额减少7080万份
证券之星 · 09-29
【ETF动向】9月28日创新药ETF银华基金涨0.48%,份额减少7080万份
【ETF动向】9月28日港股通创新药ETF汇添富基金跌0.84%,份额减少1.01亿份
证券之星 · 09-29
【ETF动向】9月28日港股通创新药ETF汇添富基金跌0.84%,份额减少1.01亿份
【ETF动向】9月23日创新药ETF银华基金涨0.35%,份额减少9480万份
证券之星 · 09-24
【ETF动向】9月23日创新药ETF银华基金涨0.35%,份额减少9480万份
ETF收评|标普生物科技ETF涨超4%,科创创新药ETF、科创200ETF、纳指科技ETF上涨,能源化工ETF、传媒ETF、油气ETF下跌
格隆汇 · 09-23
ETF收评|标普生物科技ETF涨超4%,科创创新药ETF、科创200ETF、纳指科技ETF上涨,能源化工ETF、传媒ETF、油气ETF下跌
【ETF动向】9月22日创新药ETF银华基金跌0.23%,份额减少7200万份
证券之星 · 09-23
【ETF动向】9月22日创新药ETF银华基金跌0.23%,份额减少7200万份
【ETF动向】9月22日港股通创新药ETF汇添富基金跌0.94%,份额减少7200万份
证券之星 · 09-23
【ETF动向】9月22日港股通创新药ETF汇添富基金跌0.94%,份额减少7200万份
【ETF动向】9月21日港股创新药ETF银华基金涨5.57%,份额减少1.05亿份
证券之星 · 09-22
【ETF动向】9月21日港股创新药ETF银华基金涨5.57%,份额减少1.05亿份
【ETF动向】9月21日创新药ETF银华基金涨4.07%,份额减少4.49亿份
证券之星 · 09-22
【ETF动向】9月21日创新药ETF银华基金涨4.07%,份额减少4.49亿份
ETF风向标|恒生创新药ETF、港股通创新药ETF涨6%,地产ETF涨5%,科创债ETF、中证500ETF上周“吸金”居前
格隆汇 · 09-21
ETF风向标|恒生创新药ETF、港股通创新药ETF涨6%,地产ETF涨5%,科创债ETF、中证500ETF上周“吸金”居前
ETF午评|上证指数涨0.55%,创新药板块大爆发,恒生创新药ETF、港股通创新药医疗ETF涨超5%
格隆汇 · 09-21
ETF午评|上证指数涨0.55%,创新药板块大爆发,恒生创新药ETF、港股通创新药医疗ETF涨超5%
【ETF动向】9月17日港股通创新药ETF汇添富基金涨0.93%,份额减少4600万份
证券之星 · 09-18
【ETF动向】9月17日港股通创新药ETF汇添富基金涨0.93%,份额减少4600万份
ETF热点解读|AI赋能引爆CRO上涨,港股医疗ETF、港股通医疗ETF、港股通创新药ETF、恒生生物科技ETF涨超2%
格隆汇 · 09-17
ETF热点解读|AI赋能引爆CRO上涨,港股医疗ETF、港股通医疗ETF、港股通创新药ETF、恒生生物科技ETF涨超2%
【ETF动向】9月16日创新药ETF银华基金涨0.49%,份额增加6480万份
证券之星 · 09-17
【ETF动向】9月16日创新药ETF银华基金涨0.49%,份额增加6480万份
【ETF动向】9月16日港股通创新药ETF汇添富基金跌1.07%,份额减少1.12亿份
证券之星 · 09-17
【ETF动向】9月16日港股通创新药ETF汇添富基金跌1.07%,份额减少1.12亿份
【ETF动向】9月15日创新药ETF银华基金跌0.96%,份额增加5160万份
证券之星 · 09-16
【ETF动向】9月15日创新药ETF银华基金跌0.96%,份额增加5160万份
【ETF动向】9月15日港股通创新药ETF汇添富基金跌1.19%,份额减少5500万份
证券之星 · 09-16
【ETF动向】9月15日港股通创新药ETF汇添富基金跌1.19%,份额减少5500万份
加载更多
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"159316","market":"SZ","secType":"STK","nameCN":"创新药E","latestPrice":1.189,"timestamp":1790751798000,"preClose":1.153,"halted":0,"volume":983971900,"delay":0,"changeRate":0.0312,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":0.036,"latestTime":"09-30 15:00:00","open":1.145,"high":1.194,"low":1.141,"amount":1158000000,"amplitude":0.046,"askPrice":1.189,"askSize":384,"bidPrice":1.188,"bidSize":7258,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":1.153,"symbolType":"fund","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":1.268,"lowLimit":1.038,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"committee":-0.353746,"marketValue":0,"turnoverRate":0,"status":0,"floatMarketCap":0},"requestUrl":"/m/hq/s/159316","defaultTab":"news","newsList":[{"id":"2671223705","title":"【ETF动向】9月29日创新药ETF银华基金跌0.12%,份额增加1.61亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2671223705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671223705?lang=zh_cn&edition=full","pubTime":"2026-09-30 08:04","pubTimestamp":1790726672,"startTime":"0","endTime":"0","summary":"证券之星消息,9月29日,创新药ETF银华基金(159992)跌0.12%,成交额6.87亿元。当日份额增加了1.61亿份,最新份额为192.7亿份,近20个交易日份额减少3.64亿份。当日资金净流入1.78亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为162.37亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.61%,近一个月超额回报为0.08%,管理人为银华基金公司,基金经理为马君 王帅。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000006019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671223769","title":"【ETF动向】9月29日港股通创新药ETF汇添富基金涨2.76%,份额减少1.1亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2671223769","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671223769?lang=zh_cn&edition=full","pubTime":"2026-09-30 08:02","pubTimestamp":1790726555,"startTime":"0","endTime":"0","summary":"证券之星消息,9月29日,港股通创新药ETF汇添富基金(159570)涨2.76%,成交额19.56亿元。当日份额减少了1.1亿份,最新份额为138.89亿份,近20个交易日份额减少20.65亿份。当日资金净流入3.88亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为202.84亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-4.37%,近一个月超额回报为0.28%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000005710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671237952","title":"【ETF动向】9月29日港股创新药ETF银华基金涨3.07%,份额减少9000万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2671237952","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671237952?lang=zh_cn&edition=full","pubTime":"2026-09-30 08:02","pubTimestamp":1790726554,"startTime":"0","endTime":"0","summary":"证券之星消息,9月29日,港股创新药ETF银华基金(159567)涨3.07%,成交额12.14亿元。当日份额减少了9000万份,最新份额为101.72亿份,近20个交易日份额减少2.19亿份。当日资金净流入1.31亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为71.8亿元。港股创新药ETF银华基金跟踪标的为国证港股通创新药指数,成立(2024-01-03)以来超额回报为-6.21%,近一个月超额回报为0.25%,管理人为银华基金公司,基金经理为马君。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000005705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671262634","title":"ETF热点速递|康方生物放量大涨13%,港股通创新药ETF、恒生创新药ETF、港股创新药ETF涨超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671262634","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671262634?lang=zh_cn&edition=full","pubTime":"2026-09-29 10:34","pubTimestamp":1790649296,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0348735423.USD","LU0417516902.SGD","VXUS","LU0348784397.USD","LU1961090484.USD","LU0540923850.HKD","LU1720050803.USD","09926","LU0348827113.USD","BK1161","FLHK","LU2476274308.USD","LU2399975544.HKD","BK4550","LU0561508036.HKD","LU0634319403.HKD","159316","BK4588","BK1574","LU0417516738.SGD","LU2476274720.SGD","IE00BPRC5H50.USD","LU1794554557.SGD","IE00B543WZ88.USD","LU2488822045.USD","LU0348767384.USD","LU0417516571.SGD","FDN","LU2778985437.USD","LU0348825331.USD","KCAI","BK4585","KURE","LU0348783233.USD","LU0348766576.USD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671926635","title":"【ETF动向】9月28日创新药ETF银华基金涨0.48%,份额减少7080万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2671926635","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671926635?lang=zh_cn&edition=full","pubTime":"2026-09-29 08:05","pubTimestamp":1790640312,"startTime":"0","endTime":"0","summary":"证券之星消息,9月28日,创新药ETF银华基金(159992)涨0.48%,成交额5.64亿元。当日份额减少了7080万份,最新份额为191.09亿份,近20个交易日份额减少1.17亿份。当日资金净流出6525.42万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为160.59亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.59%,近一个月超额回报为0.08%,管理人为银华基金公司,基金经理为马君 王帅。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900006537.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671266330","title":"【ETF动向】9月28日港股通创新药ETF汇添富基金跌0.84%,份额减少1.01亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2671266330","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671266330?lang=zh_cn&edition=full","pubTime":"2026-09-29 08:02","pubTimestamp":1790640167,"startTime":"0","endTime":"0","summary":"证券之星消息,9月28日,港股通创新药ETF汇添富基金(159570)跌0.84%,成交额12.13亿元。当日份额减少了1.01亿份,最新份额为139.99亿份,近20个交易日份额减少20.95亿份。当日资金净流出4.21亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为198.96亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-4.43%,近一个月超额回报为0.15%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900006218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669943472","title":"【ETF动向】9月23日创新药ETF银华基金涨0.35%,份额减少9480万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2669943472","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669943472?lang=zh_cn&edition=full","pubTime":"2026-09-24 07:33","pubTimestamp":1790206434,"startTime":"0","endTime":"0","summary":"证券之星消息,9月23日,创新药ETF银华基金(159992)涨0.35%,成交额5.12亿元。当日份额减少了9480万份,最新份额为190.13亿份,近20个交易日份额减少6660万份。当日资金净流出1371.5万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为165.47亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.85%,近一个月超额回报为0.08%,管理人为银华基金公司,基金经理为马君 王帅。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400007106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669683103","title":"ETF收评|标普生物科技ETF涨超4%,科创创新药ETF、科创200ETF、纳指科技ETF上涨,能源化工ETF、传媒ETF、油气ETF下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2669683103","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669683103?lang=zh_cn&edition=full","pubTime":"2026-09-23 15:07","pubTimestamp":1790147268,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159945","159982","159870","159509","159805","000699.SH","161127","159697","159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669738911","title":"【ETF动向】9月22日创新药ETF银华基金跌0.23%,份额减少7200万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2669738911","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669738911?lang=zh_cn&edition=full","pubTime":"2026-09-23 08:02","pubTimestamp":1790121767,"startTime":"0","endTime":"0","summary":"证券之星消息,9月22日,创新药ETF银华基金(159992)跌0.23%,成交额6.9亿元。当日份额减少了7200万份,最新份额为191.08亿份,近20个交易日份额减少1.97亿份。当日资金净流出1.14亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为165.61亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.82%,近一个月超额回报为0.08%,管理人为银华基金公司,基金经理为马君 王帅。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300006987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669173894","title":"【ETF动向】9月22日港股通创新药ETF汇添富基金跌0.94%,份额减少7200万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2669173894","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669173894?lang=zh_cn&edition=full","pubTime":"2026-09-23 08:01","pubTimestamp":1790121689,"startTime":"0","endTime":"0","summary":"证券之星消息,9月22日,港股通创新药ETF汇添富基金(159570)跌0.94%,成交额18亿元。当日份额减少了7200万份,最新份额为141.07亿份,近20个交易日份额减少23.87亿份。当日资金净流出2.78亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为210.68亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-5.14%,近一个月超额回报为-0.18%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300006683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669191913","title":"【ETF动向】9月21日港股创新药ETF银华基金涨5.57%,份额减少1.05亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2669191913","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669191913?lang=zh_cn&edition=full","pubTime":"2026-09-22 08:32","pubTimestamp":1790037131,"startTime":"0","endTime":"0","summary":"证券之星消息,9月21日,港股创新药ETF银华基金(159567)涨5.57%,成交额13.18亿元。当日份额减少了1.05亿份,最新份额为102.78亿份,近20个交易日份额减少3.51亿份。当日资金净流入3.49亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为74.79亿元。港股创新药ETF银华基金跟踪标的为国证港股通创新药指数,成立(2024-01-03)以来超额回报为-7.13%,近一个月超额回报为-0.26%,管理人为银华基金公司,基金经理为马君。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200005175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669199473","title":"【ETF动向】9月21日创新药ETF银华基金涨4.07%,份额减少4.49亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2669199473","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669199473?lang=zh_cn&edition=full","pubTime":"2026-09-22 08:02","pubTimestamp":1790035361,"startTime":"0","endTime":"0","summary":"证券之星消息,9月21日,创新药ETF银华基金(159992)涨4.07%,成交额12.03亿元。当日份额减少了4.49亿份,最新份额为191.8亿份,近20个交易日份额减少3.36亿份。当日资金净流入2.75亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为166.75亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.84%,近一个月超额回报为0.09%,管理人为银华基金公司,基金经理为马君 王帅。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200004149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669125159","title":"ETF风向标|恒生创新药ETF、港股通创新药ETF涨6%,地产ETF涨5%,科创债ETF、中证500ETF上周“吸金”居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2669125159","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669125159?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:45","pubTimestamp":1789980307,"startTime":"0","endTime":"0","summary":"8张图速览","market":"hk","thumbnail":"https://img3.gelonghui.com/50dc3-0be91cd7-b99d-4450-8079-5a8b6fbc2fb6.jpg?guru_height=3264&guru_width=5824&guru_size=1288273","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/50dc3-0be91cd7-b99d-4450-8079-5a8b6fbc2fb6.jpg?guru_height=3264&guru_width=5824&guru_size=1288273"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6756066","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_fund_highlight","symbols":["159707","512880","159316","159967","000688.SH","512510","159115","515890","510880","000001.SH","000300.SH","159982","399905","510300","399001","000905.SH","399006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669348701","title":"ETF午评|上证指数涨0.55%,创新药板块大爆发,恒生创新药ETF、港股通创新药医疗ETF涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669348701","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669348701?lang=zh_cn&edition=full","pubTime":"2026-09-21 11:36","pubTimestamp":1789961790,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["513120","520500","159316","520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668918075","title":"【ETF动向】9月17日港股通创新药ETF汇添富基金涨0.93%,份额减少4600万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2668918075","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668918075?lang=zh_cn&edition=full","pubTime":"2026-09-18 08:02","pubTimestamp":1789689771,"startTime":"0","endTime":"0","summary":"证券之星消息,9月17日,港股通创新药ETF汇添富基金(159570)涨0.93%,成交额14.42亿元。当日份额减少了4600万份,最新份额为143.63亿份,近20个交易日份额减少21.97亿份。当日资金净流入1.03亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为203.37亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-4.66%,近一个月超额回报为-0.09%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800004025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668930082","title":"ETF热点解读|AI赋能引爆CRO上涨,港股医疗ETF、港股通医疗ETF、港股通创新药ETF、恒生生物科技ETF涨超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668930082","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668930082?lang=zh_cn&edition=full","pubTime":"2026-09-17 10:34","pubTimestamp":1789612464,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4550","FLHK","ARTY","159892","VXUS","VTHR","AIPO","BK4588","FDN","AGIX","BK4585","KCAI","QTOC","159828","CHAT","159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668393108","title":"【ETF动向】9月16日创新药ETF银华基金涨0.49%,份额增加6480万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2668393108","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668393108?lang=zh_cn&edition=full","pubTime":"2026-09-17 08:05","pubTimestamp":1789603512,"startTime":"0","endTime":"0","summary":"证券之星消息,9月16日,创新药ETF银华基金(159992)涨0.49%,成交额4.56亿元。当日份额增加了6480万份,最新份额为195.66亿份,近20个交易日份额增加1亿份。当日资金净流入1.28亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为161.65亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.49%,近一个月超额回报为0.11%,管理人为银华基金公司,基金经理为马君 王帅。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700004701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668931749","title":"【ETF动向】9月16日港股通创新药ETF汇添富基金跌1.07%,份额减少1.12亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2668931749","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668931749?lang=zh_cn&edition=full","pubTime":"2026-09-17 08:02","pubTimestamp":1789603355,"startTime":"0","endTime":"0","summary":"证券之星消息,9月16日,港股通创新药ETF汇添富基金(159570)跌1.07%,成交额11.37亿元。当日份额减少了1.12亿份,最新份额为144.09亿份,近20个交易日份额减少27.87亿份。当日资金净流出3.72亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为202.34亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-4.61%,近一个月超额回报为-0.09%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700004357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667789336","title":"【ETF动向】9月15日创新药ETF银华基金跌0.96%,份额增加5160万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2667789336","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667789336?lang=zh_cn&edition=full","pubTime":"2026-09-16 08:04","pubTimestamp":1789517089,"startTime":"0","endTime":"0","summary":"证券之星消息,9月15日,创新药ETF银华基金(159992)跌0.96%,成交额4.27亿元。当日份额增加了5160万份,最新份额为195.01亿份,近20个交易日份额减少1.15亿份。当日资金净流出1.17亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为160.38亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.45%,近一个月超额回报为0.11%,管理人为银华基金公司,基金经理为马君 王帅。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600004776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667678541","title":"【ETF动向】9月15日港股通创新药ETF汇添富基金跌1.19%,份额减少5500万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2667678541","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667678541?lang=zh_cn&edition=full","pubTime":"2026-09-16 08:02","pubTimestamp":1789516964,"startTime":"0","endTime":"0","summary":"证券之星消息,9月15日,港股通创新药ETF汇添富基金(159570)跌1.19%,成交额10.69亿元。当日份额减少了5500万份,最新份额为145.21亿份,近20个交易日份额减少28.4亿份。当日资金净流出3.59亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为206.06亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-4.67%,近一个月超额回报为-0.1%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600004476.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791156652861,"stockEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":0.0277},{"period":"3month","weight":0.1123},{"period":"6month","weight":-0.1107},{"period":"1year","weight":-0.2513},{"period":"ytd","weight":-0.0541}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创新药E(159316)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创新药E(159316)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创新药E,159316,创新药E股票,创新药E股票老虎,创新药E股票老虎国际,创新药E行情,创新药E股票行情,创新药E股价,创新药E股市,创新药E股票价格,创新药E股票交易,创新药E股票购买,创新药E股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创新药E(159316)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创新药E(159316)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}